Mitral stenosis screening

Mitral Stenosis Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Mitral Stenosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Stages
History and Symptoms
Physical Examination
Electrocardiogram
Chest X Ray
Echocardiography
Cardiac MRI
Cardiac Catheterization
Treatment
Overview
Medical Therapy
Percutaneous Mitral Balloon Commissurotomy (PMBC)
Surgery
Follow Up
Prevention
Case Studies
Case #1
Mitral stenosis screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Mitral stenosis screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA onMitral stenosis screening
CDC on Mitral stenosis screening
Mitral stenosis screening in the news
Blogs on Mitral stenosis screening
Directions to Hospitals Treating Mitral Stenosis
Risk calculators and risk factors for Mitral stenosis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

According to the 2014 and 2017 AHA/ACC Guideline, screening for mitral stenosis by TTE is recommended every [duration] among patients with signs or symptoms.

Screening

Exercise testing with Doppler or invasive hemodynamic assessment is recommended to evaluate the response of the mean mitral gradient and pulmonary artery pressure in patients with MS when there is a discrepancy between resting Doppler echocardiographic findings and clinical symptoms or signs.

OR

According to the 2014 and 2017 AHA/ACC Guideline, screening for mitral stenosis by TTE is recommended every [duration] among patients with signs or symptoms.

• [Condition 1]
• [Condition 2]
• [Condition 3]